Home
Aurobindo Pharma Limited
Press Release Apr 12 2025
Business
Apr 13 2025
3 min read

Press Release Apr 12 2025

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 12, 2025, titled "Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg and tentative approval for other strengths of Rivaroxaban Tablets USP".

View Attachment